semisolids (week10) Flashcards
skin pH
5.5
main layers
epidermis
dermis
subcutaneous
layers of epidermis
stratum corneum
stratum lucidum
stratum spinosum
stratum germinativum/basale
epidermis cell types/what prod
keratinocytes - produce insol keratin protein and lipids
melanocytes
dendritic (langerhans) cells
Dermis
-matrix of CT
-
-matrix of CT: 75% collagen 4% elastin
- contains BVs and nerves and appendages (sweat glands, sebaceous glands, hair follicles)
-contains fibroblasts, mast cells, histocytes
-SITE OF DRUG METABOLISM
maintians “sink conditinon” due to vasculature
Epidermis
epidermis cells = viable portion of epidermis
stratum corneum dead cells
+forms impermeabble layer
+rss permeation of external cpds
SERVES AS RATE LIMITING factor in absorbtion of drugs
Targets for drmatologicla treatment ()
skin surface startum corneum skin apendages viable epidermis and dermis systemic treatment bia percutaneous absorption
targets for dermatological treatment: skin surface
- camoflauge or cosmetic preparations
-protective films - barriers, sunscreans, antifungal and antibacterial preps (polysporin)
-
targets for dermatological preparations: stratum corneum
emolients and moisurizers
+increase water content
keratolytics (remove dead cells)
skin appendges
antiperspirants (seat glands) - aluminum salts
exfoliants (in acne) - salicylic acid, tretinoin, benzoyl peroxide
depilatories - thioglycolates
antibiotics - clindamycin, tetracyclin, erythromycin
antifungals - clotrimazole, miconazole
targets for dermatological treatement: viable dermis and epidermis
topical steroidal/nonsteroidal antiinflammatory agents
local anesthetic agents
antihistamines/antipruritic
anticancer drugs
target regions for dermatological treatment: systemic treatment by percutaneous absorption
motion sickness - scopolamine
angina - nitraglycerine
hypertension - clonidine
smoking cessation - nicotine
selection of vehicle for optimum bioavailability
- Skin disease or condition
- Rate of the release of the drug from the vehicle (drug favors skin over vehicle)
- Promotion of percutaneous absorption
- Requirement for occlusion
- Short and long term stability of the drug in the ointment base
- Influence of the drug on the consistency of the base
pH above what is irritating to skin
above 8
criteria for dermatological formulations
1) physiochemical criteria
2) cosmetic (aesthetic) criteria
physiochmeical criteria Iderm form)
- Stability of the active ingredient
- Stability of adjuvants
- Rheological properties (consistency, extrudability)
- Prevention of loss of water or volatile compounds
- Phase changes – homogeneity, phase separation, bleeding)
- Particle size, particle distribution of the dispersed phase
- Apparent pH
- Particulate contamination
criteria for dermatoologic formulations: cosmetic
- Pharmaceutical elegance ——> non-compliance
• Easy transfer from container
• Spreads readily and smoothly
• Leaves no residue
• Adheres to treated area without being tacky or difficult to remove
Dermatologic vehicles (ointments) (5)
hydrocarbon bases absorbing bases emulsifying bases water soluble bases silicone bases
dermatologic vehicles: creams and lotions (2)
O/W emulsitons
W/O emusionts
Dermatologic vehicles powders
dusting powders
dermatological vehicles: liquids
linments
soaks
tinctures
dermatological vehicles: what are they (7)
ointments emmulsions pastels gels aerosols powders liquids
ointments
semisolid preps
hydrophillic or greasy
usually anhydrous
may contain dissolbed or dispersed medicaitons
creams
semisolid preparations, both oil and water